Principles for adoptive T cell therapy of human viral diseases.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Annual Review of Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.IY.13.040195.002553PMID 7612234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.

  1994cited by this paper
• Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals.

  1994cited by this paper
• Virus-specific CD8+ T-cell memory determined by clonal burst size

  1994cited by this paper
• Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

  1994cited by this paper
• Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell.

  1994cited by this paper
• Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12

  1994cited by this paper
• Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes

  1994cited by this paper
• Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice

  1994cited by this paper
• Cytotoxic T-cell memory without antigen

  1994cited by this paper
• Resistance to murine acquired immunodeficiency syndrome (MAIDS)

  1994cited by this paper
• Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.

  1994cited by this paper
• Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.

  1994cited by this paper
• Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

  1994cited by this paper
• Infection and Apoptotic Cell Death of CD4+ T Cells during an Immune Response to HIV-1-Pulsed Dendritic Cells

  1994cited by this paper
• Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.

  1994cited by this paper
• Immunology. The hole truth about perforin.

  1994cited by this paper
• Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

  1994cited by this paper
• Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein

  1994cited by this paper
• Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

  1994cited by this paper
• The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen

  1994cited by this paper
• Cytokine-mediated regulation of chronic intestinal helminth infection

  1994cited by this paper
• Subversion of the immune system by pathogens.

  1994cited by this paper
• Borna disease virus-specific T cells protect against or cause immunopathological Borna disease

  1994cited by this paper
• Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line

  1994cited by this paper
• Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes

  1994cited by this paper
• MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.

  1994cited by this paper
• Promethean viruses?

  1994cited by this paper
• MHC class I expression in mice lacking the proteasome subunit LMP-7.

  1994cited by this paper
• The immune system of mice lacking conventional MHC class II molecules.

  1994cited by this paper
• MHC class I-deficient mice.

  1994cited by this paper
• Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

  1994cited by this paper
• Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

  1994cited by this paper
• Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions

  1994cited by this paper
• Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia

  1994cited by this paper
• Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells.

  1994cited by this paper
• MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice.

  1994cited by this paper
• Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis.

  1994cited by this paper
• Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

  1994cited by this paper
• A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

  1994cited by this paper
• Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection

  1994cited by this paper
• Turnover of naive- and memory-phenotype T cells

  1994cited by this paper
• Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro

  1994cited by this paper
• Immunology. Memories are made of this?

  1994cited by this paper
• Distinct types of lung disease caused by functional subsets of antiviral T cells

  1994cited by this paper
• Donor T cells to treat EBV-associated lymphoma.

  1994cited by this paper
• Environmental modulation of the autonomy of cytotoxic T lymphocytes

  1993cited by this paper
• HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• Slowing the spread of HIV: agenda for the 1990s.

  1993cited by this paper
• MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

  1993cited by this paper
• Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse

  1993cited by this paper
• Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.

  1993cited by this paper
• Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS)

  1993cited by this paper
• HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

  1993cited by this paper
• Interleukin-10.

  1993cited by this paper
• The SCID-hu mouse as a model for HIV-1 infection

  1993cited by this paper
• Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease

  1993cited by this paper
• Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.

  1993cited by this paper
• Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.

  1993cited by this paper
• Cell-mediated cytotoxicity.

  1993cited by this paper
• Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice

  1993cited by this paper
• Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein

  1993cited by this paper
• Disruption of the murine IL-4 gene blocks Th2 cytokine responses

  1993cited by this paper
• Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

  1993cited by this paper
• Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus

  1993cited by this paper
• Immune responses in interleukin-2-deficient mice.

  1993cited by this paper
• Immune response in mice that lack the interferon-gamma receptor.

  1993cited by this paper
• The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory

  1993cited by this paper
• Peripheral clonal deletion of antiviral memory CD8+ T cells

  1993cited by this paper
• Response to influenza infection in mice with a targeted disruption in the interferon gamma gene

  1993cited by this paper
• HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.

  1993cited by this paper
• Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains.

  1993cited by this paper
• A case for cytokines as effector molecules in the resolution of virus infection.

  1993cited by this paper
• The IL-2/IL-2 receptor system: a current overview.

  1993cited by this paper
• Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

  1993cited by this paper
• Theiler's virus infection of beta 2-microglobulin-deficient mice

  1993cited by this paper
• Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.

  1993cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry.

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS.

  1993cited by this paper
• High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.

  1993cited by this paper
• Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.

  1993cited by this paper
• HIV induces thymus depletion in vivo

  1993cited by this paper
• Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.

  1993cited by this paper
• Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia

  1993cited by this paper
• Isolation of a herpes simplex virus type 1 mutant with a deletion in the virion host shutoff gene and identification of multiple forms of the vhs (UL41) polypeptide

  1993cited by this paper
• A possible role for bcl-2 in regulating T-cell memory--a 'balancing act' between cell death and survival.

  1993cited by this paper
• Early and progressive helper T-cell dysfunction in feline leukemia virus-induced immunodeficiency.

  1992cited by this paper
• Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

  1992cited by this paper
• Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.

  1992cited by this paper
• Human gene therapy comes of age

  1992cited by this paper
• HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

  1992cited by this paper
• Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen

  1992cited by this paper
• Virus proteins that counteract host immune defenses.

  1992cited by this paper
• Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

  1992cited by this paper
• The role of T cell immunity in control of herpes simplex virus.

  1992cited by this paper
• Transgenic mice lacking class I major histocompatibility complex- restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

  1992cited by this paper

• Influence of different conjugation methods for activating antibodies on polymeric nanoparticles: Effects for polyclonal expansion of human CD8+ T cells.

  2024cites this paper
• Cytomegalovirus in haematopoietic cell transplantation - The troll is still there.

  2024cites this paper
• SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

  2021cites this paper
• Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment

  2021cites this paper
• Cellular Therapies in Onco-Hematology: 60 Years of Progress

  2020cites this paper
• Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State.

  2019cites this paper
• A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

  2018cites this paper
• Übertragung des koff-rate-Assays an CD8+ zytotoxischen T-Zellen vom murinen auf das humane System

  2018cites this paper
• Mécanismes de l’immunogénicité des cellules cancéreuses hyperploïdes

  2017cites this paper
• Therapeutic T cell engineering

  2017cites this paper
• T cell receptor binding avidity of antigen-specific CD8 + cytotoxic T cells in chronic infection

  2016cites this paper
• Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity

  2016cites this paper
• Immunotherapeutic strategies for sexually transmitted viral infections : HIV , HSV and 1 HPV 2 3

  2016cites this paper
• Lipid Rafts, Pseudotyping, and Virus-Like Particles: Relevance of a Novel, Configurable, and Modular Antigen-Presenting Platform

  2016cites this paper
• Cancer Immunotherapy : Evolving Oncolytic viruses and CAR T-cells

  2016cites this paper
• Interleukin-15 Overexpression Attenuates Muscle Fatigue Associated with Murine EO771 Mammary Tumors

  2016cites this paper
• Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.

  2016cites this paper
• Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV

  2016cites this paper
• The generation of MHC class I restricted islet antigen specific regulatory T cells for the treatment of type 1 diabetes

  2015cites this paper
• Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV

  2015cites this paper
• New cell sources for T cell engineering and adoptive immunotherapy.

  2015cites this paper
• Immunotherapy in Cancer Treatment

  2014cites this paper
• Cell-mediated immunity to human CMV infection: a brief overview

  2014cites this paper
• Génération efficace de lymphocytes t ciblant une tumeur dérivés de cellules souches pluripotentes

  2014cites this paper
• A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients

  2014cites this paper
• Suppression of cytomegalovirus-specific CD8+T cells by everolimus

  2014cites this paper
• for CD4+ T Cell-Mediated Antiviral Qualitative and Quantitative Requirements

  2013cites this paper
• Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

  2013cites this paper
• This information is current as Following Bone Marrow Transplantation without Producing Graft-versus-Host Disease Prevent Lethal Cytomegalovirus Disease Allogeneic T Cells Treated with Amotosalen

  2013cites this paper
• Cancer testis antigen and immunotherapy

  2013cites this paper
• Therapeutic genes for anti-HIV/AIDS gene therapy.

  2013cites this paper
• transplantation murine cytomegalovirus infection after hematopoietic stem cell Common lymphoid progenitors rapidly engraft and protect against lethal

  2013cites this paper
• of tumor-antigen presenting cells and T-lymphocyte transfer Complete responses of relapsed lymphoma following genetic modification

  2013cites this paper
• CD8 co-receptor modifications to enhance T cell immunotherapy

  2013cites this paper
• dendritic cells repertoire diversity following in vitro restimulation by antigen-pulsed specific CD8+ T-cell - Characterization of human cytomegalovirus peptide

  2013cites this paper
• Insights into thymic involution in tumor-bearing mice

  2013cites this paper
• Immunotherapy in pediatric hemato-oncology

  2013cites this paper
• naive and memory populations depleting therapy affecting - Defective T-helper cell function after T-cell

  2013cites this paper
• Immunosenescence and the 3Rs: Restoration, Replacement and Reprogramming

  2012cites this paper
• Development of a novel TCR avidity assay for human CD8+ T cells

  2012cites this paper
• Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes.

  2012cites this paper
• T-cell therapy for cancer.

  2012cites this paper
• T-cell therapy for viral infections following transplantation: why stop at three viruses?

  2012cites this paper
• Cellular immunotherapy for cancer. Past, present, future

  2012cites this paper
• Immunotherapy of brain tumors.

  2012cites this paper
• Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections

  2012cites this paper
• Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cells

  2012cites this paper
• NanoAPC deliver antigen, IL-2 and co-stimulatory molecules to antigen specific T cells and activate viral specific T cells in chronic infections

  2011cites this paper
• Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

  2011cites this paper
• The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

  2011cites this paper
• Lipid Rafts, Pseudotyping, and Virus-Like Particles: Relevance of a Novel, Configurable, and Modular Antigen-Presenting Platform

  2010cites this paper
• T-cell therapy for cytomegalovirus infection

  2010cites this paper
• Entwicklung neuer Verfahren zur Herstellung autologer Epstein-Barr Virus-spezifischer T-Zellen zur Adoptiven Immuntherapie

  2010cites this paper
• Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

  2010cites this paper
• In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

  2009cites this paper
• Etablierung und Evaluierung eines Mikroneutralisationstests mit Trophoblasten- Primärkulturen zur Abschätzung des HCMV-Transmissionsrisikos bei maternaler Primärinfektion

  2009cites this paper
• Immunotherapy of viral infections.

  2009cites this paper
• Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host.

  2009cites this paper
• Persistent Viral Infection Elevates Central Nervous System MHC Class I through Chronic Production of Interferons1

  2009cites this paper
• Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications

  2009cites this paper
• Multiple roles for CD4+ T cells in anti‐tumor immune responses

  2008cites this paper
• Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.

  2008cites this paper
• Immunotherapy of malignant brain tumors

  2008cites this paper
• Concepts in genetic medicine

  2008cites this paper
• TCR β-Chain Sharing in Human CD8+ T Cell Responses to Cytomegalovirus and EBV1

  2008cites this paper
• Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.

  2008cites this paper
• The C ontribution of Homeostatically Expanded Donor CD8 T Cells to Host Reconstitution Following Syngeneic Hematopoietic Cell Transplantation

  2008cites this paper
• CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model

  2008cites this paper
• Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

  2008cites this paper
• TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV.

  2008cites this paper
• Efficient in vitro priming of tumor- and virus-specific CD8+ T cells with calibrated artifical APCs

  2008cites this paper
• Adoptive CD8 T cell control of pathogens cannot be improved by combining protective epitope specificities.

  2008cites this paper
• Selective Modification of Antigen-Specific T Cells by RNA Electroporation

  2008cites this paper
• Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response.

  2008cites this paper
• Redirecting Therapeutic T Cells against Myelin-Specific T Lymphocytes Using a Humanized Myelin Basic Protein-HLA-DR2-ζ Chimeric Receptor1

  2008cites this paper
• Cellular Immunology: Monitoring of Immune Therapies

  2008cites this paper
• Positive Selection and Expansion of Cytomegalovirus-specific CD4 and CD8 T Cells in Sealed Systems: Potential Applications for Adoptive Cellular Immunoreconstitution

  2008cites this paper
• Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.

  2008cites this paper
• Origin of CD8+ effector and memory T cell subsets.

  2007cites this paper
• Induction of tolerance and immunity by redirected B cell-specific cytolytic T lymphocytes

  2007cites this paper
• Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

  2007cites this paper
• T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy

  2007cites this paper
• Immune responses to gene-modified T cells.

  2007cites this paper
• Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

  2007influential citation
• Adoptive immunotherapy of HCMV infection.

  2007cites this paper
• An investigation of the relationship between the systemic and local inflammatory responses and survival in patients with primary operable colorectal cancer

  2007cites this paper
• Rapid Generation of CMV pp65-specific T cells for Immunotherapy

  2007influential citation
• REVIEW Adoptive immunotherapy of HCMV infection

  2007cites this paper
• Chapter 46 – Human Herpesvirus Infections

  2007cites this paper
• Protection against Vaccinia Virus Challenge by CD8 Memory T Cells Resolved by Molecular Mimicry

  2006cites this paper
• A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus‐specific human CD4 and CD8 T lymphocytes

  2006cites this paper
• Efficient priming and expansion of antigen‐specific CD8+ T cells by a novel cell‐based artificial APC

  2006cites this paper
• The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes.

  2006cites this paper
• Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques.

  2006cites this paper
• Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner1

  2006cites this paper
• Vaccine-enhanced donor lymphocyte infusion (veDLI).

  2006cites this paper
• Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.

  2006cites this paper
• T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120

  2005cites this paper
• Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.

  2005cites this paper
• Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire.

  2005cites this paper